查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572471

离心血泵市场、机会、成长动力、产业趋势分析与预测，2024-2032

Centrifugal Blood Pumps Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 102 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球离心血泵市场价值约为 9,510 万美元，预计 2024 年至 2032 年复合年增长率为 5.3%。人口老化、肥胖、高血压和糖尿病等因素正在增加心臟衰竭和冠状动脉疾病的发生率。例如，国家医学图书馆2023 年的一项研究强调，约670 万美国成年人患有心臟衰竭(HF)，预计到2030 年这一数字将增至850 万。 ，四分之一的美国人患有心臟衰竭(HF)。离心血泵对于治疗严重心臟衰竭病例和复杂的心臟手术至关重要，可改善患者的治疗效果并推动市场成长。

技术进步在市场扩张中发挥了至关重要的作用。磁浮技术等创新技术可以最大限度地减少机械磨损并提高泵浦的可靠性，已经改变了整个产业。此外，先进的监测和控制系统的整合可以即时了解帮浦的性能和患者状况，从而提高安全性和有效性。这些进步不仅提高了离心血泵的性能和可靠性，还扩大了其在急性和慢性心血管护理中的应用，推动市场成长。

离心血泵产业根据产品类型、最终用途和地区进行分类。

市场分为电气和机械领域，预计到 2032 年，电气领域将达到 1.138 亿美元。这些帮浦配备了尖端技术，可以进行即时调整併提高效率，特别是在复杂的外科手术或重症监护期间。此外，电子和小型化的进步为更复杂、更可靠的电动帮浦铺平了道路，进一步提高了它们的市场占有率。

分为短期和长期支持申请，长期支持部分在 2023 年将达到 3,710 万美元。离心泵在体外膜氧合（ECMO）和心室辅助装置（VAD）等先进疗法中的使用不断增加，增强了该细分市场的实力。 ECMO 系统对于心臟和呼吸支援至关重要，需要长期帮浦解决方案才能持续运作。同样，VAD 透过提高泵血效率来帮助严重心臟衰竭患者，大大受益于专为长期使用而设计的离心泵的耐用性和效率。

预计到 2032 年，美国离心血泵市场将达到 5,840 万美元。随着这些情况变得越来越普遍，对先进医疗设备（尤其是离心血泵）的需求激增，突显了它们在管理严重心臟问题和支持心臟手术患者方面的重要性。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 心血管疾病盛行率不断上升
      • 离心血泵的技术进步
      • 心血管研究和开发的投资不断增加
    • 产业陷阱与挑战
      • 设备成本高
      • 严格的监管场景
  • 成长潜力分析
  • 监管环境
  • 技术景观
    • 核心技术
    • 邻近技术
  • 未来市场趋势
  • 差距分析
  • 波特的分析
  • 杵分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032

  • 主要趋势
  • 电力
  • 机械的

第 6 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 短期支持
  • 长期支持

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 9 章：公司简介

  • Abbott Laboratories
  • Braile Biomedica
  • Getinge AB
  • Hugo Sachs Elektronik
  • LivaNova PLC
  • Medtronic plc
  • Senko Medical Instrument Mfg. Co., Ltd.
  • Spectrum Medical
  • Terumo Corporation
简介目录
Product Code: 10857

The Global Centrifugal Blood Pumps Market was valued at approximately USD 95.1 million in 2023 and is projected to grow at 5.3% CAGR from 2024 to 2032. The rising prevalence of cardiovascular diseases (CVDs) significantly drives the market. Factors like an aging population, obesity, hypertension, and diabetes are increasing the incidence of heart failure and coronary artery disease. For instance, a 2023 study from the National Library of Medicine highlighted that about 6.7 million U.S. adults have heart failure (HF), a number projected to rise to 8.5 million by 2030. With a lifetime risk of 24%, it's estimated that one in four individuals will face heart failure at some point. Centrifugal blood pumps are pivotal in managing severe heart failure cases and intricate cardiac procedures, leading to improved patient outcomes and propelling market growth.

Technological advancements have played a crucial role in market expansion. Innovations like magnetic levitation technology, which minimizes mechanical wear and boosts pump reliability, have transformed the industry. Furthermore, the integration of advanced monitoring and control systems offers real-time insights into pump performance and patient conditions, enhancing safety and efficacy. These advancements not only elevate the performance and reliability of centrifugal blood pumps but also expand their application in both acute and chronic cardiovascular care, driving market growth.

The centrifugal blood pumps industry is classified based on product type, end-use, and region.

Divided into electrical and mechanical segments, the market forecasts the electrical segment to reach USD 113.8 million by 2032. Valued for their precision control and superior performance, electrical centrifugal blood pumps are becoming increasingly sought after in contemporary medical environments. These pumps, equipped with cutting-edge technology, allow real-time adjustments and heightened efficiency, especially during intricate surgical procedures or in critical care. Moreover, advancements in electronics and miniaturization are paving the way for more sophisticated and dependable electrical pumps, further boosting their market presence.

Segmented into short-term and long-term support applications, the long-term support segment leading with USD 37.1 million in 2023. This dominance stems from the rising demand for durable solutions to address chronic cardiovascular issues. The segment's strength is bolstered by the growing utilization of centrifugal pumps in advanced therapies like extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs). ECMO systems, vital for cardiac and respiratory support, necessitate long-term pump solutions for consistent operation. Likewise, VADs, aiding severe heart failure patients by enhancing blood pumping efficiency, greatly benefit from the durability and efficiency of centrifugal pumps designed for prolonged use.

The U.S. Centrifugal Blood Pumps Market is projected to hit USD 58.4 million by 2032. The rising prevalence of CVDs, including heart failure and coronary artery disease, is a primary driver. As these conditions become more common, the demand for advanced medical devices, particularly centrifugal blood pumps, surges, underscoring their importance in managing severe cardiac issues and supporting heart surgery patients.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of cardiovascular diseases
      • 3.2.1.2 Technological advancements in centrifugal blood pumps
      • 3.2.1.3 Growing investment in cardiovascular research and development
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of devices
      • 3.2.2.2 Stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
    • 3.5.1 Core technologies
    • 3.5.2 Adjacent technologies
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTLE analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Electrical
  • 5.3 Mechanical

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Short-term support
  • 6.3 Long-term support

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Specialty clinics
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Braile Biomedica
  • 9.3 Getinge AB
  • 9.4 Hugo Sachs Elektronik
  • 9.5 LivaNova PLC
  • 9.6 Medtronic plc
  • 9.7 Senko Medical Instrument Mfg. Co., Ltd.
  • 9.8 Spectrum Medical
  • 9.9 Terumo Corporation